PGIM Custom Harvest’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$455K Buy
2,090
+30
+1% +$6.66K 0.01% 189
2025
Q4
$471K Sell
2,060
-2,435
-54% -$555K 0.01% 172
2025
Q3
$1.04M Sell
4,495
-329
-7% -$67K 0.02% 126
2025
Q2
$895K Sell
4,824
-168
-3% -$31.2K 0.02% 120
2025
Q1
$1.05M Sell
4,992
-423
-8% -$82.2K 0.03% 108
2024
Q4
$962K Buy
5,415
+343
+7% +$63.1K 0.02% 115
2024
Q3
$1M Buy
5,072
+300
+6% +$56K 0.02% 116
2024
Q2
$818K Buy
4,772
+224
+5% +$37.1K 0.02% 124
2024
Q1
$828K Buy
4,548
+965
+27% +$166K 0.02% 109
2023
Q4
$555K Buy
3,583
+272
+8% +$39.7K 0.02% 120
2023
Q3
$494K Buy
3,311
+142
+4% +$20.8K 0.02% 119
2023
Q2
$427K Buy
+3,169
New +$465K 0.02% 121

Other funds holding ABBV

PGIM Custom Harvest's ABBV Position: Q1 2026 in Review

PGIM Custom Harvest increased its AbbVie (ABBV) stake by 1.5% in Q1 2026, buying an estimated $6.66K and bringing the position to 2,090 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #189.

PGIM Custom Harvest first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • PGIM Custom Harvest held 2,090 shares of AbbVie worth $455K as of Q1 2026.
  • PGIM Custom Harvest bought 30 AbbVie shares in Q1 2026, an estimated $6.66K.
  • AbbVie made up 0.01% of PGIM Custom Harvest's portfolio in Q1 2026, its #189 holding.
  • PGIM Custom Harvest first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
  • PGIM Custom Harvest's AbbVie position peaked at $1.05M in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on PGIM Custom Harvest's 13F filing for Q1 2026, filed 13 May 2026.